Please be sure to review the Continuing Medical Education (CME) registration form and assessment questions for 2012, inserted in this month's issue.
Minocycline for Psychotic Depression?
In a small, open-label trial of patients with psychotic depression, adjunctive minocycline (Minocin) was associated with a large improvement in depressive symptoms.
Looking Back. Looking Ahead.
Dr. Gelenberg's end-of-year editorial and holiday message.
INDEX Volume 35, 2012
NAC, Marijuana, and Adolescents
Preliminary data suggest that treatment with N-acetylcysteine (NAC), in addition to contingency management and counseling, might reduce marijuana use in cannabis-dependent adolescents.
Finasteride and Persistent Psychiatric Side Effects
Depression, suicidal thoughts, and sexual dysfunction associated with finasteride (Propecia, Proscar, and others) may persist long after the medication is discontinued.
Bath Salts and the Serotonin Syndrome
People who abuse "bath salts," especially patients taking serotonergic drugs, are at risk for developing the serotonin syndrome.
FDA Announces that Budeprion XL 300 mg Is Not Therapeutically Equivalent to Wellbutrin XL 300 mg; Excess Mortality Due to Alcohol Dependence Higher in Women than in Men
On October 3, 2012, the US FDA announced that after reviewing new data, it has determined that the 300-mg extended-release tablets of bupropion hydrochloride manufactured by Impax Laboratories, Inc. and marketed by Teva Pharmaceuticals USA, Inc. under the name Budeprion XL are "not therapeutically…